Anne M. Dittrich

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Key Principles and Disease-Specific Considerations to Guide Management of Bone Health and Osteoporosis Among Individuals With Neuromuscular Disorders: The Path Forward.

Key Principles and Disease-Specific Considerations to Guide Management of Bone Health and Osteoporosis Among Individuals With Neuromuscular Disorders: The Path Forward.

Journal: Muscle & nerve

Published: August 18, 2025

Uncovering the Hidden Hurdles: Exploring Challenges in Pediatric Pharmacovigilance in the Netherlands.

Uncovering the Hidden Hurdles: Exploring Challenges in Pediatric Pharmacovigilance in the Netherlands.

Journal: Drug safety

Published: July 13, 2025

A Retrospective, Nationwide, Multicenter Study on Diagnosis and Treatment Outcome of Pediatric Optic Pathway/Hypothalamic Gliomas Including Analysis of Risk Factors for Progression After Systemic Anticancer Therapy.

A Retrospective, Nationwide, Multicenter Study on Diagnosis and Treatment Outcome of Pediatric Optic Pathway/Hypothalamic Gliomas Including Analysis of Risk Factors for Progression After Systemic Anticancer Therapy.

Journal: Cancers

Published: January 20, 2025

The ins and outs of glycopyrronium treatment for paediatric drooling: exploring the treatment journey using real-world data.

The ins and outs of glycopyrronium treatment for paediatric drooling: exploring the treatment journey using real-world data.

Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society

Published: November 12, 2024

274th ENMC international workshop: recommendations for optimizing bone strength in neuromuscular disorders. Hoofddorp, The Netherlands, 19-21 January 2024.

274th ENMC international workshop: recommendations for optimizing bone strength in neuromuscular disorders. Hoofddorp, The Netherlands, 19-21 January 2024.

Journal: Neuromuscular disorders : NMD

Published: June 17, 2024

Treatment evaluation by volumetric segmentation in pediatric optic pathway glioma: evaluation of the effect of bevacizumab on intra-tumor components.

Treatment evaluation by volumetric segmentation in pediatric optic pathway glioma: evaluation of the effect of bevacizumab on intra-tumor components.

Journal: Journal of neuro-oncology

Published: October 16, 2023

SELENON-Related Myopathy Across the Life Span, a Cross-Sectional Study for Preparing Trial Readiness.

SELENON-Related Myopathy Across the Life Span, a Cross-Sectional Study for Preparing Trial Readiness.

Journal: Journal of neuromuscular diseases

Published: October 09, 2023

Bone quality in LAMA2-related muscular dystrophy and SELENON-related congenital myopathy, a one-year prospective natural history study.

Bone quality in LAMA2-related muscular dystrophy and SELENON-related congenital myopathy, a one-year prospective natural history study.

Journal: Neuromuscular disorders : NMD

Published: September 12, 2023

LAMA2-Related Muscular Dystrophy Across the Life Span: A Cross-sectional Study.

LAMA2-Related Muscular Dystrophy Across the Life Span: A Cross-sectional Study.

Journal: Neurology. Genetics

Published: January 12, 2023

Impact of Bevacizumab on Visual Function, Tumor Size, and Toxicity in Pediatric Progressive Optic Pathway Glioma: A Retrospective Nationwide Multicentre Study.

Impact of Bevacizumab on Visual Function, Tumor Size, and Toxicity in Pediatric Progressive Optic Pathway Glioma: A Retrospective Nationwide Multicentre Study.

Journal: Cancers

Published: November 04, 2022

Bone Quality in Patients with a Congenital Myopathy: A Scoping Review.

Bone Quality in Patients with a Congenital Myopathy: A Scoping Review.

Journal: Journal of neuromuscular diseases

Published: October 31, 2022

Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical Care.

Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical Care.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 24, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026